Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference
02 Agosto 2023 - 5:05PM
Business Wire
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA
testing, today announced that members of its leadership team will
present at the Canaccord Genuity 43rd Annual Growth Conference on
Wednesday, Aug. 9 at 4:30 pm ET | 1:30 pm PT in Boston, MA.
A live webcast and audio archive of the event may be accessed
through the investor relations section of the Natera website at
investor.natera.com. A replay of the event will be available
shortly following the conference.
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated
to oncology, women’s health, and organ health. We aim to make
personalized genetic testing and diagnostics part of the standard
of care to protect health, and inform earlier, more targeted
interventions that help lead to longer, healthier lives. Natera’s
tests are validated by more than 150 peer-reviewed publications
that demonstrate high accuracy. Natera operates ISO 13485-certified
and CAP-accredited laboratories certified under the Clinical
Laboratory Improvement Amendments (CLIA) in Austin, Texas and San
Carlos, California. For more information, visit www.natera.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230801498467/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc.,
510-826-2350, investor@natera.com Media: Lesley Bogdanow, VP of
Corporate Communications, Natera, Inc., pr@natera.com
Natera (NASDAQ:NTRA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Natera (NASDAQ:NTRA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
